The FASEB Journal, Vol 7, 920-925, Copyright © 1993 by The Federation of American Societies for Experimental Biology

REVIEWS

Multiple steps in carcinogenesis involving alterations of multiple tumor suppressor genes

J Yokota and T Sugimura
National Cancer Center Research Institute, Tokyo, Japan.

Recent advances in molecular genetics have made it possible to understand the molecular mechanisms of human cancer progression. The results indicate that clinically evident tumor cells already carry multiple genetic alterations and further accumulation of genetic alteration occurs during tumor progression. It is widely accepted that tumor suppressor genes play a central role in the genesis and progression of human cancers, as frequent alterations of tumor suppressor genes have been found in a variety of human cancers. Molecular analyses of various stages of human cancers, from precancerous lesions to advanced or metastatic tumors, indicate that sequential accumulation of genetic alterations correlates with more malignant phenotypes of tumor cells. Furthermore, biological studies of tumor suppressor genes have revealed that a single gene defect is not sufficient for the cells to gain growth advantage and start clonal expansion in vivo. These results are consistent with the concept of human multistage carcinogenesis, indicated by experimental animal models and epidemiological studies. Although it is supposed that there are more than 20 tumor suppressor genes in the human genome, only a few tumor suppressor genes have been identified to date. Thus, further studies should focus on the identification and characterization of novel tumor suppressor genes, and molecular analysis of those genes in human cancer would be of great help in clarifying the multiple steps in the process of human carcinogenesis.

This article has been cited by other articles:

				S. Choi and J.N. Myers Molecular Pathogenesis of Oral Squamous Cell Carcinoma: Implications for Therapy J. Dent. Res., January 1, 2008; 87(1): 14 - 32. [Abstract] [Full Text] [PDF]

				K.-H. Tung, M. T. Goodman, A. H. Wu, K. McDuffie, L. R. Wilkens, A. M. Y. Nomura, and L. N. Kolonel Aggregation of Ovarian Cancer with Breast, Ovarian, Colorectal, and Prostate Cancer in First-degree Relatives Am. J. Epidemiol., April 15, 2004; 159(8): 750 - 758. [Abstract] [Full Text] [PDF]

				M.-R. Lee, S.-H. Kim, H.-J. Cho, K.-Y. Lee, A. R. Moon, H. G. Jeong, J.-S. Lee, J.-W. Hyun, M.-H. Chung, and H. J. You Transcription Factors NF-YA Regulate the Induction of Human OGG1 Following DNA-alkylating Agent Methylmethane Sulfonate (MMS) Treatment J. Biol. Chem., March 12, 2004; 279(11): 9857 - 9866. [Abstract] [Full Text] [PDF]

				V. Patel, T. Lahusen, T. Sy, E. A. Sausville, J. S. Gutkind, and A. M. Senderowicz Perifosine, a Novel Alkylphospholipid, Induces p21WAF1 Expression in Squamous Carcinoma Cells through a p53-independent Pathway, Leading to Loss in Cyclin-dependent Kinase Activity and Cell Cycle Arrest Cancer Res., March 1, 2002; 62(5): 1401 - 1409. [Abstract] [Full Text] [PDF]

				N Leonard, R Chaggar, C Jones, M Takahashi, A Nikitopoulou, and S R Lakhani Loss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours J. Clin. Pathol., September 1, 2001; 54(9): 689 - 692. [Abstract] [Full Text] [PDF]

				H K Williams Molecular pathogenesis of oral squamous carcinoma Mol. Pathol., August 1, 2000; 53(4): 165 - 172. [Abstract] [Full Text]

				J. Yokota Tumor progression and metastasis Carcinogenesis, March 1, 2000; 21(3): 497 - 503. [Abstract] [Full Text] [PDF]

				Y. Tomizawa, J.-i. Adachi, T. Kohno, K. Hamada, R. Saito, M. Noguchi, Y. Matsuno, S. Hirohashi, N. Yamaguchi, and J. Yokota Prognostic Significance of Allelic Imbalances on Chromosome 9p in Stage I Non-Small Cell Lung Carcinoma Clin. Cancer Res., May 1, 1999; 5(5): 1139 - 1146. [Abstract] [Full Text] [PDF]

				S. K. G. Grebe, B. McIver, I. D. Hay, P. S.-C. Wu, L. M. Z. Maciel, H. A. Drabkin, J. R. Goellner, C. S. Grant, R. B. Jenkins, and N. L. Eberhardt Frequent Loss of Heterozygosity on Chromosomes 3p and 17p without VHL or p53 Mutations Suggests Involvement of Unidentified Tumor Suppressor Genes in Follicular Thyroid Carcinoma J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3684 - 3691. [Abstract] [Full Text] [PDF]